Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Plew Daniel P Van. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Plew Daniel P Van zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:REGN / Regeneron Pharmaceuticals, Inc. | EVP & General Mgr, Industrial | 21 673 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Plew Daniel P Van. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Plew Daniel P Van ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -2 552 | 21 673 | -10,53 | 701,51 | -1 790 254 | 15 203 826 | |
| 2025-12-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 906 | 24 225 | -7,29 | 712,94 | -1 358 864 | 17 270 972 | |
| 2025-12-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 715 | 26 131 | 16,57 | ||||
| 2024-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -969 | 34 792 | -2,71 | 730,81 | -708 155 | 25 426 342 | |
| 2024-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -492 | 35 761 | -1,36 | 787,00 | -387 204 | 28 143 907 | |
| 2024-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 499 | 36 253 | 10,68 | ||||
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 | 20 378 | -0,97 | 951,77 | -190 354 | 19 395 169 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -375 | 20 578 | -1,79 | 950,45 | -356 419 | 19 558 360 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -112 | 20 953 | -0,53 | 949,07 | -106 296 | 19 885 864 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -150 | 21 065 | -0,71 | 948,70 | -142 305 | 19 984 366 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -240 | 21 215 | -1,12 | 947,81 | -227 474 | 20 107 789 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -95 | 21 455 | -0,44 | 945,81 | -89 852 | 20 292 354 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -620 | 21 550 | -2,80 | 944,30 | -585 466 | 20 349 665 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 691 | 22 170 | -10,82 | 943,51 | -2 538 985 | 20 917 617 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -275 | 24 861 | -1,09 | 941,41 | -258 888 | 23 404 394 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4 261 | 25 136 | -14,49 | 940,44 | -4 007 215 | 23 638 900 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -750 | 29 397 | -2,49 | 939,60 | -704 700 | 27 621 421 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -226 | 30 147 | -0,74 | 938,13 | -212 017 | 28 281 805 | |
| 2024-02-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -439 | 30 373 | -1,42 | 937,94 | -411 756 | 28 488 052 | |
| 2024-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -16 341 | 30 812 | -34,66 | 951,68 | -15 551 403 | 29 323 164 | |
| 2024-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 23 125 | 47 153 | 96,24 | 381,40 | 8 819 875 | 17 984 154 | |
| 2024-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -8 600 | 24 028 | -26,36 | 951,68 | -8 184 448 | 22 866 967 | |
| 2024-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 12 250 | 32 628 | 60,11 | 372,46 | 4 562 635 | 12 152 625 | |
| 2023-12-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -669 | 20 378 | -3,18 | 844,09 | -564 696 | 17 200 866 | |
| 2023-12-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -2 552 | 21 047 | -10,81 | 844,09 | -2 154 118 | 17 765 562 | |
| 2023-12-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 199 | 23 599 | 15,68 | ||||
| 2023-12-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 108 | 20 400 | -5,15 | 843,79 | -934 919 | 17 213 316 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 534 | 21 508 | -10,54 | 844,27 | -2 139 380 | 18 158 559 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -759 | 24 042 | -3,06 | 843,31 | -640 072 | 20 274 859 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -617 | 24 801 | -2,43 | 842,66 | -519 921 | 20 898 811 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -363 | 25 418 | -1,41 | 841,15 | -305 337 | 21 380 351 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -46 | 25 781 | -0,18 | 840,74 | -38 674 | 21 675 118 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -148 | 25 827 | -0,57 | 839,28 | -124 213 | 21 676 085 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -667 | 25 975 | -2,50 | 838,37 | -559 193 | 21 776 661 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 | 26 642 | -1,11 | 837,53 | -251 259 | 22 313 474 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -625 | 26 942 | -2,27 | 836,32 | -522 700 | 22 532 133 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -138 | 27 567 | -0,50 | 835,67 | -115 322 | 23 036 915 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -16 928 | 27 705 | -37,93 | 842,66 | -14 264 548 | 23 345 895 | |
| 2023-08-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 23 125 | 44 633 | 107,52 | 381,40 | 8 819 875 | 17 023 026 | |
| 2022-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 798 | 33 884 | 12,62 | ||||
| 2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -492 | 30 086 | -1,61 | 753,28 | -370 614 | 22 663 182 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 | 30 578 | 0,00 | 748,17 | -748 | 22 877 542 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -629 | 30 579 | -2,02 | 747,28 | -470 039 | 22 851 075 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 164 | 31 208 | -3,60 | 746,42 | -868 833 | 23 294 275 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -256 | 32 372 | -0,78 | 745,56 | -190 863 | 24 135 268 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -780 | 32 628 | -2,33 | 744,56 | -580 757 | 24 293 504 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -101 | 33 408 | -0,30 | 743,66 | -75 110 | 24 844 193 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -99 | 33 509 | -0,29 | 742,58 | -73 515 | 24 883 113 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 002 | 33 608 | -2,90 | 741,34 | -742 823 | 24 914 955 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 808 | 34 610 | -4,96 | 740,29 | -1 338 444 | 25 621 437 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 124 | 36 418 | -7,90 | 739,48 | -2 310 136 | 26 930 383 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -944 | 39 542 | -2,33 | 738,57 | -697 210 | 29 204 535 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -373 | 40 486 | -0,91 | 737,37 | -275 039 | 29 853 162 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 005 | 40 859 | -2,40 | 736,46 | -740 142 | 30 091 019 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -686 | 41 864 | -1,61 | 735,57 | -504 601 | 30 793 902 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -38 028 | 42 550 | -47,19 | 741,81 | -28 209 551 | 31 564 016 | |
| 2022-11-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 50 000 | 80 578 | 163,52 | 378,98 | 18 949 000 | 30 537 450 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -404 | 30 578 | -1,30 | 747,20 | -301 869 | 22 847 882 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 782 | 30 982 | -8,24 | 746,56 | -2 076 930 | 23 129 922 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 468 | 33 764 | -4,17 | 745,51 | -1 094 409 | 25 171 400 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 032 | 35 232 | -5,45 | 744,61 | -1 513 048 | 26 234 100 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 100 | 37 264 | -2,87 | 743,39 | -817 729 | 27 701 685 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 38 364 | -0,26 | 742,79 | -74 279 | 28 496 396 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -26 114 | 38 464 | -40,44 | 725,84 | -18 954 586 | 27 918 710 | |
| 2022-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 34 000 | 64 578 | 111,19 | 381,92 | 12 985 280 | 24 663 630 | |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -79 | 30 578 | -0,26 | 722,83 | -57 104 | 22 102 696 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -174 | 30 657 | -0,56 | 721,38 | -125 520 | 22 115 347 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -181 | 30 831 | -0,58 | 720,41 | -130 394 | 22 210 961 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -159 | 31 012 | -0,51 | 719,72 | -114 435 | 22 319 957 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -435 | 31 171 | -1,38 | 718,50 | -312 548 | 22 396 364 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -647 | 31 606 | -2,01 | 717,59 | -464 281 | 22 680 150 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 052 | 32 253 | -3,16 | 716,28 | -753 527 | 23 102 179 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -861 | 33 305 | -2,52 | 715,39 | -615 951 | 23 826 064 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -267 | 34 166 | -0,78 | 714,42 | -190 750 | 24 408 874 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -572 | 34 433 | -1,63 | 713,67 | -408 219 | 24 573 799 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -110 | 35 005 | -0,31 | 712,44 | -78 368 | 24 938 962 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -70 | 35 115 | -0,20 | 711,85 | -49 830 | 24 996 613 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 | 35 185 | -0,01 | 710,25 | -1 420 | 24 990 146 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -87 | 35 187 | -0,25 | 709,93 | -61 764 | 24 980 307 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | -35 304 | 35 274 | -50,02 | 730,96 | -25 805 812 | 25 783 883 |
| 2022-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 40 000 | 70 578 | 130,81 | 555,67 | 22 226 800 | 39 218 077 |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 015 | 30 578 | -3,21 | 618,16 | -627 432 | 18 902 096 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 176 | 31 593 | -3,59 | 617,48 | -726 156 | 19 508 046 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -734 | 32 769 | -2,19 | 616,40 | -452 438 | 20 198 812 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 | 33 503 | -0,89 | 615,20 | -184 560 | 20 611 046 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -600 | 33 803 | -1,74 | 614,53 | -368 718 | 20 772 958 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -600 | 34 403 | -1,71 | 612,44 | -367 464 | 21 069 773 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -800 | 35 003 | -2,23 | 611,65 | -489 320 | 21 409 585 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 | 35 803 | -0,56 | 610,41 | -122 082 | 21 854 509 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -400 | 36 003 | -1,10 | 609,62 | -243 848 | 21 948 149 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -800 | 36 403 | -2,15 | 608,29 | -486 632 | 22 143 581 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -156 | 37 203 | -0,42 | 607,94 | -94 839 | 22 617 192 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -40 000 | 0 | -100,00 | ||||
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -33 219 | 37 359 | -47,07 | 610,56 | -20 282 193 | 22 809 911 | |
| 2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 40 000 | 70 578 | 130,81 | 399,66 | 15 986 400 | 28 207 203 | |
| 2021-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -697 | 30 578 | -2,23 | 664,34 | -463 045 | 20 314 189 | |
| 2021-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 18 548 | 18 548 | |||||
| 2021-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 344 | 31 275 | 16,13 | ||||
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -500 | 26 931 | -1,82 | 660,51 | -330 255 | 17 788 195 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 403 | 27 431 | -8,05 | 659,42 | -1 584 586 | 18 088 550 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -697 | 29 834 | -2,28 | 658,50 | -458 974 | 19 645 689 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 | 30 531 | -0,65 | 657,18 | -131 436 | 20 064 363 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -350 | 30 731 | -1,13 | 655,03 | -229 260 | 20 129 727 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 260 | 31 081 | -3,90 | 654,33 | -824 456 | 20 337 231 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -840 | 32 341 | -2,53 | 653,41 | -548 864 | 21 131 933 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -528 | 33 181 | -1,57 | 652,20 | -344 362 | 21 640 648 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -25 000 | 0 | -100,00 | ||||
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -18 222 | 33 709 | -35,09 | 641,50 | -11 689 413 | 21 624 324 | |
| 2021-11-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 25 000 | 51 931 | 92,83 | 270,43 | 6 760 750 | 14 043 700 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 | 26 931 | -1,10 | 616,27 | -184 881 | 16 596 767 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -280 | 27 231 | -1,02 | 615,22 | -172 262 | 16 753 056 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 120 | 27 511 | -3,91 | 614,33 | -688 050 | 16 900 833 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 600 | 28 631 | -5,29 | 613,34 | -981 344 | 17 560 538 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -900 | 30 231 | -2,89 | 612,45 | -551 205 | 18 514 976 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -400 | 31 131 | -1,27 | 611,57 | -244 628 | 19 038 786 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 31 531 | -0,32 | 610,81 | -61 081 | 19 259 450 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 | 31 631 | -0,63 | 609,25 | -121 850 | 19 271 187 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -697 | 31 831 | -2,14 | 608,50 | -424 124 | 19 369 164 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -762 | 32 528 | -2,29 | 607,21 | -462 694 | 19 751 327 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -244 | 33 290 | -0,73 | 606,50 | -147 986 | 20 190 385 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -25 000 | 25 000 | -50,00 | ||||
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -18 397 | 33 534 | -35,43 | 617,68 | -11 363 459 | 20 713 281 | |
| 2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 25 000 | 51 931 | 92,83 | 270,43 | 6 760 750 | 14 043 700 | |
| 2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 19 950 | 19 950 | |||||
| 2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 000 | 26 931 | 22,80 | ||||
| 2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 930 | 21 931 | 9,65 | ||||
| 2020-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 288 | 20 001 | -6,05 | 614,24 | -791 141 | 12 285 414 | |
| 2020-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 560 | 21 289 | -6,83 | 613,62 | -957 247 | 13 063 356 | |
| 2020-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4 044 | 22 849 | -15,04 | 612,49 | -2 476 910 | 13 994 784 | |
| 2020-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 980 | 26 893 | -6,86 | 611,40 | -1 210 572 | 16 442 380 | |
| 2020-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -7 981 | 28 873 | -21,66 | 610,41 | -4 871 682 | 17 624 368 | |
| 2020-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -10 256 | 36 854 | -21,77 | 609,71 | -6 253 186 | 22 470 252 | |
| 2020-08-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -75 000 | 0 | -100,00 | ||||
| 2020-08-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -47 891 | 47 110 | -50,41 | 614,09 | -29 409 384 | 28 929 780 | |
| 2020-08-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 75 000 | 95 001 | 374,98 | 179,13 | 13 434 750 | 17 017 529 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -700 | 28 251 | -2,42 | 569,42 | -398 594 | 16 086 684 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 040 | 28 951 | -9,50 | 568,57 | -1 728 453 | 16 460 670 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 753 | 31 991 | -10,50 | 567,35 | -2 129 265 | 18 150 094 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -7 297 | 35 744 | -16,95 | 566,47 | -4 133 532 | 20 247 904 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -5 984 | 43 041 | -12,21 | 565,49 | -3 383 892 | 24 339 255 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 000 | 49 025 | -5,77 | 564,54 | -1 693 620 | 27 676 574 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 195 | 52 025 | -4,05 | 563,58 | -1 237 058 | 29 320 250 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 077 | 54 220 | -3,69 | 562,45 | -1 168 209 | 30 496 039 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4 988 | 56 297 | -8,14 | 561,55 | -2 801 011 | 31 613 580 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 231 | 61 285 | -5,01 | 560,53 | -1 811 072 | 34 352 081 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -500 | 64 516 | -0,77 | 559,20 | -279 600 | 36 077 347 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 118 | 65 016 | -3,15 | 558,43 | -1 182 755 | 36 306 885 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -600 | 67 134 | -0,89 | 557,59 | -334 554 | 37 433 247 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 67 734 | -0,15 | 556,92 | -55 692 | 37 722 419 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -52 500 | 0 | -100,00 | ||||
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -33 079 | 52 500 | -38,65 | ||||
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -28 217 | 67 834 | -29,38 | 555,77 | -15 682 162 | 37 700 102 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 52 500 | 96 051 | 120,55 | 52,03 | 2 731 575 | 4 997 534 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -17 779 | 43 551 | -28,99 | 555,77 | -9 881 035 | 24 204 339 | |
| 2020-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 33 079 | 61 330 | 117,09 | 52,03 | 1 721 100 | 3 191 000 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -210 | 28 251 | -0,74 | 460,30 | -96 663 | 13 003 935 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 425 | 28 461 | -4,77 | 459,33 | -654 545 | 13 072 991 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -5 274 | 29 886 | -15,00 | 458,45 | -2 417 865 | 13 701 237 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 787 | 35 160 | -9,72 | 457,59 | -1 732 893 | 16 088 864 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 435 | 38 947 | -3,55 | 456,50 | -655 078 | 17 779 306 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 300 | 40 382 | -3,12 | 455,50 | -592 150 | 18 394 001 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -711 | 41 682 | -1,68 | 454,53 | -323 171 | 18 945 719 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 000 | 42 393 | -2,30 | 453,57 | -453 570 | 19 228 193 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 | 43 393 | -0,69 | 452,53 | -135 759 | 19 636 634 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 | 43 693 | -0,46 | 451,61 | -90 322 | 19 732 196 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -32 735 | 0 | -100,00 | ||||
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -17 093 | 43 893 | -28,03 | 447,30 | -7 645 699 | 19 633 339 | |
| 2020-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 32 735 | 60 986 | 115,87 | 30,63 | 1 002 673 | 1 868 001 | |
| 2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 24 500 | 24 500 | |||||
| 2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 000 | 28 251 | 21,50 | ||||
| 2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 625 | 23 251 | 12,73 | ||||
| 2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 46 250 | 46 250 | |||||
| 2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | |||||
| 2016-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 34 000 | 34 000 | |||||
| 2016-05-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -4 413 | 1 921 | -69,67 | 385,77 | -1 702 403 | 741 064 | |
| 2016-05-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -9 460 | 32 735 | -22,42 | ||||
| 2016-05-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 301 | 6 334 | -40,44 | 388,14 | -1 669 390 | 2 458 479 | |
| 2016-05-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -746 | 10 635 | -6,55 | 388,14 | -289 552 | 4 127 869 | |
| 2016-05-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 9 460 | 11 381 | 492,45 | 30,63 | 289 760 | 348 600 | |
| 2015-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
| 2015-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -1 921 | 0 | -100,00 | ||||
| 2015-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 921 | 1 921 | 52,03 | 99 950 | 99 950 | ||
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 223 | 0 | -100,00 | 557,14 | -681 382 | ||
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 1 223 | -44,98 | 556,00 | -556 000 | 679 988 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 2 223 | -47,36 | 554,39 | -1 108 780 | 1 232 409 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -50 | 4 223 | -1,17 | 552,50 | -27 625 | 2 333 208 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 4 273 | -16,59 | 551,45 | -468 732 | 2 356 346 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -5 486 | 42 195 | -11,51 | ||||
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -5 700 | 47 681 | -10,68 | ||||
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -2 674 | 5 123 | -34,30 | 559,49 | -1 496 076 | 2 866 267 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -300 | 7 797 | -3,71 | 559,49 | -167 847 | 4 362 344 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 486 | 8 097 | 210,11 | 30,63 | 168 036 | 248 011 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -2 778 | 2 611 | -51,55 | 559,49 | -1 554 263 | 1 460 828 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -311 | 5 389 | -5,46 | 559,49 | -174 001 | 3 015 092 | |
| 2015-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 700 | 5 700 | 30,63 | 174 591 | 174 591 | ||
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 128 | 0 | -100,00 | 586,24 | -661 279 | ||
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -900 | 1 128 | -44,38 | 585,02 | -526 518 | 659 903 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 2 028 | -33,03 | 583,89 | -583 890 | 1 184 129 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 3 028 | -24,83 | 582,12 | -582 120 | 1 762 659 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -4 605 | 53 381 | -7,94 | ||||
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -4 095 | 0 | -100,00 | ||||
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -2 035 | 4 028 | -33,56 | 588,64 | -1 197 882 | 2 371 042 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -147 | 6 063 | -2,37 | 588,64 | -86 530 | 3 568 924 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 095 | 6 210 | 193,62 | 21,25 | 87 019 | 131 962 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -2 251 | 2 115 | -51,56 | 588,64 | -1 325 029 | 1 244 974 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -239 | 4 366 | -5,19 | 588,64 | -140 685 | 2 570 002 | |
| 2015-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 605 | 4 605 | 30,63 | 141 051 | 141 051 | ||
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -99 | 0 | -100,00 | 510,02 | -50 492 | ||
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -7 506 | 99 | -98,70 | 509,34 | -3 823 106 | 50 425 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 886 | 7 605 | -33,82 | 508,53 | -1 976 148 | 3 867 371 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 879 | 11 491 | -37,45 | 507,34 | -3 489 992 | 5 829 844 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -26 250 | 57 986 | -31,16 | ||||
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -13 800 | 4 095 | -77,12 | ||||
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -6 823 | 18 370 | -27,08 | 516,48 | -3 523 943 | 9 487 738 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -567 | 25 193 | -2,20 | 516,48 | -292 844 | 13 011 681 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 800 | 25 760 | 115,38 | 21,25 | 293 250 | 547 400 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -12 734 | 11 960 | -51,57 | 516,48 | -6 576 856 | 6 177 101 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1 556 | 24 694 | -5,93 | 516,48 | -803 643 | 12 753 957 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 26 250 | 26 250 | 30,63 | 804 038 | 804 038 | ||
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 331 | 18 705 | -15,12 | 429,09 | -1 429 299 | 8 026 128 | |
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 100 | 22 036 | -8,70 | 428,27 | -899 367 | 9 437 358 | |
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 700 | 24 136 | -6,58 | 427,12 | -726 104 | 10 308 968 | |
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 300 | 25 836 | -8,17 | 426,08 | -979 984 | 11 008 203 | |
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -20 000 | 17 895 | -52,78 | ||||
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -9 569 | 28 136 | -25,38 | 424,70 | -4 063 954 | 11 949 359 | |
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1 000 | 37 705 | -2,58 | 424,70 | -424 700 | 16 013 314 | |
| 2015-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 20 000 | 38 705 | 106,92 | 21,25 | 425 000 | 822 481 | |
| 2014-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -3 264 | 0 | -100,00 | ||||
| 2014-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 264 | 18 705 | 21,14 | 30,63 | 99 976 | 572 934 | |
| 2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
| 2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 52 500 | 85 579 | 158,71 | ||||
| 2014-11-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 501 | 15 441 | -8,86 | 399,95 | -600 325 | 6 175 628 | |
| 2014-11-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -7 074 | 16 942 | -29,46 | 399,21 | -2 824 012 | 6 763 416 | |
| 2014-11-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -18 700 | 37 895 | -33,04 | ||||
| 2014-11-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -9 129 | 24 016 | -27,54 | 398,93 | -3 641 832 | 9 580 703 | |
| 2014-11-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -996 | 33 145 | -2,92 | 398,93 | -397 334 | 13 222 535 | |
| 2014-11-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 700 | 34 141 | 121,11 | 21,25 | 397 375 | 725 496 | |
| 2014-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 806 | 15 441 | -30,59 | 338,37 | -2 302 946 | 5 224 771 | |
| 2014-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -15 000 | 56 595 | -20,95 | ||||
| 2014-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -7 246 | 22 247 | -24,57 | 336,11 | -2 435 453 | 7 477 439 | |
| 2014-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -948 | 29 493 | -3,11 | 336,11 | -318 632 | 9 912 892 | |
| 2014-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 000 | 30 441 | 97,14 | 21,25 | 318 750 | 646 871 | |
| 2014-05-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 369 | 15 441 | -13,30 | 296,70 | -702 882 | 4 581 345 | |
| 2014-05-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 000 | 17 810 | -14,42 | 295,33 | -885 990 | 5 259 827 | |
| 2014-05-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -11 200 | 71 595 | -13,53 | ||||
| 2014-05-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -5 028 | 20 810 | -19,46 | 296,19 | -1 489 243 | 6 163 714 | |
| 2014-05-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -803 | 25 838 | -3,01 | 296,19 | -237 841 | 7 652 957 | |
| 2014-05-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 11 200 | 26 641 | 72,53 | 21,25 | 238 000 | 566 121 | |
| 2013-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -4 705 | 0 | -100,00 | ||||
| 2013-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 705 | 15 441 | 43,82 | 21,25 | 99 981 | 328 121 | |
| 2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | |||||
| 2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 52 500 | 84 236 | 165,43 | ||||
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 10 736 | -8,52 | 308,26 | -308 260 | 3 309 479 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 200 | 11 736 | -21,42 | 307,28 | -983 296 | 3 606 238 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 600 | 14 936 | -19,42 | 306,40 | -1 103 040 | 4 576 390 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 556 | 18 536 | -16,10 | 305,14 | -1 085 078 | 5 656 075 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 444 | 22 092 | -6,14 | 304,16 | -439 207 | 6 719 503 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -600 | 23 536 | -2,49 | 303,01 | -181 806 | 7 131 643 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 400 | 24 136 | -5,48 | 301,42 | -421 988 | 7 275 073 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 600 | 25 536 | -9,24 | 300,62 | -781 612 | 7 676 632 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 800 | 28 136 | -9,05 | 299,34 | -838 152 | 8 422 230 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 777 | 30 936 | -10,88 | 298,28 | -1 126 604 | 9 227 590 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -52 500 | 0 | -100,00 | |||
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -25 531 | 34 713 | -42,38 | 294,75 | -7 525 262 | 10 231 657 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -2 992 | 60 244 | -4,73 | 294,75 | -881 892 | 17 756 919 |
| 2013-09-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 52 500 | 63 236 | 489,01 | 16,80 | 882 000 | 1 062 365 |
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 037 | 10 736 | -15,95 | 262,15 | -534 000 | 2 814 442 | |
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -10 988 | 12 773 | -46,24 | 261,56 | -2 874 021 | 3 340 906 | |
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -700 | 23 761 | -2,86 | 260,88 | -182 616 | 6 198 770 | |
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -29 048 | 52 500 | -35,62 | ||||
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -3 902 | 0 | -100,00 | ||||
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -13 450 | 24 461 | -35,48 | 260,44 | -3 502 918 | 6 370 623 | |
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1 873 | 37 911 | -4,71 | 260,44 | -487 804 | 9 873 541 | |
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 048 | 39 784 | 270,57 | 16,80 | 488 006 | 668 371 | |
| 2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 902 | 10 736 | 57,10 | 16,80 | 65 554 | 180 365 | |
| 2012-12-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -2 050 | 3 902 | -34,44 | ||||
| 2012-12-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 050 | 6 834 | 42,85 | 16,80 | 34 440 | 114 811 | |
| 2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 75 000 | 75 000 | |||||
| 2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 52 500 | 82 795 | 173,30 | ||||
| 2012-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -4 384 | 4 784 | -47,82 | 157,44 | -690 217 | 753 193 | |
| 2012-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -400 | 9 168 | -4,18 | 156,94 | -62 776 | 1 438 826 | |
| 2012-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 9 568 | -17,29 | 156,17 | -312 340 | 1 494 235 | |
| 2012-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 900 | 11 568 | -37,36 | 155,18 | -1 070 742 | 1 795 122 | |
| 2012-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -4 400 | 18 468 | -19,24 | 154,77 | -680 988 | 2 858 292 | |
| 2012-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -657 | 22 868 | -2,79 | 153,48 | -100 836 | 3 509 781 | |
| 2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -30 000 | 0 | -100,00 | ||||
| 2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -11 922 | 23 525 | -33,63 | 159,55 | -1 902 155 | 3 753 414 | |
| 2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 121 | 35 447 | -10,41 | 159,55 | -657 506 | 5 655 569 | |
| 2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 30 000 | 39 568 | 313,55 | 21,92 | 657 600 | 867 331 | |
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -13 143 | 9 568 | -57,87 | 136,42 | -1 792 968 | 1 305 267 | |
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 299 | 22 711 | -5,41 | 135,94 | -176 586 | 3 087 333 | |
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -30 432 | 0 | -100,00 | ||||
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -4 784 | 0 | -100,00 | ||||
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 784 | 24 010 | 24,88 | 20,90 | 99 986 | 501 809 | |
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -11 394 | 19 226 | -37,21 | 138,36 | -1 576 474 | 2 660 109 | |
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 596 | 30 620 | -13,05 | 138,36 | -635 903 | 4 236 583 | |
| 2012-04-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 30 432 | 35 216 | 636,12 | 20,90 | 636 029 | 736 014 |